Main > ONCOLOGY (**) > Pancreas Cancer>MET *** > Treatment > Co: JP. A. Erlotinib.HCl Tab.+***

---

Co: JP. A. Erlotinib.HCl Tab.+***'s subsections
(*) EU Approval Date: 2007. 01.29
(*) USA Approval Date: 2005. 11.
+Gemcitabine
Company
Marketing EU:
Marketing USA:
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2007. 01.23
Patent>USA Expiration: 2016. 05.28
TradeMark
TradeMark Web-Site

Co: JP. A. Erlotinib.HCl Tab.+***'s products
This section has no products